News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
90,779 Results
Type
Article (6943)
Company Profile (41)
Press Release (83795)
Section
Business (27799)
Career Advice (130)
Deals (4012)
Drug Delivery (39)
Drug Development (14287)
Employer Resources (19)
FDA (2864)
Job Trends (2122)
News (49452)
Policy (6068)
Tag
Academia (422)
Allergies (20)
Alliances (8938)
Alzheimer's disease (246)
Antibody-drug conjugate (ADC) (30)
Approvals (2838)
Artificial intelligence (25)
Bankruptcy (18)
Best Places to Work (1772)
Biosimilars (58)
Biotechnology (29)
Breast cancer (24)
Cancer (232)
Cardiovascular disease (21)
Career advice (112)
Cell therapy (50)
Clinical research (11230)
Collaboration (86)
Compensation (16)
COVID-19 (536)
C-suite (22)
Data (201)
Diabetes (27)
Diagnostics (504)
Drug pricing (24)
Earnings (9174)
Events (11457)
Executive appointments (36)
FDA (3000)
Funding (63)
Gene therapy (48)
GLP-1 (127)
Government (1306)
Healthcare (1943)
Immunology and inflammation (22)
Infectious disease (557)
Inflammatory bowel disease (41)
IPO (1825)
Job creations (387)
Job search strategy (109)
Layoffs (65)
Legal (581)
Lung cancer (58)
Manufacturing (72)
Medical device (1156)
Medtech (1157)
Mergers & acquisitions (2226)
Metabolic disorders (79)
Neuroscience (301)
NextGen Class of 2024 (696)
Non-profit (347)
Northern California (254)
Obesity (47)
Opinion (44)
Patents (16)
Peanut (18)
People (7817)
Phase I (3668)
Phase II (4673)
Phase III (4130)
Pipeline (100)
Policy (32)
Postmarket research (296)
Preclinical (1437)
Press Release (66)
Radiopharmaceuticals (34)
Rare diseases (37)
Real estate (912)
Regulatory (4580)
Research institute (386)
Southern California (269)
Startups (580)
United States (2320)
Vaccines (151)
Weight loss (41)
Date
Today (5)
Last 7 days (199)
Last 30 days (588)
Last 365 days (6734)
2024 (5993)
2023 (7035)
2022 (9060)
2021 (9476)
2020 (8175)
2019 (5843)
2018 (4518)
2017 (5059)
2016 (4620)
2015 (5276)
2014 (3735)
2013 (2894)
2012 (2988)
2011 (3153)
2010 (2580)
Location
Africa (91)
Asia (7310)
Australia (866)
California (595)
Canada (152)
China (88)
Colorado (21)
Delaware (17)
Europe (13526)
Florida (64)
Illinois (31)
Indiana (26)
Maryland (222)
Massachusetts (401)
Minnesota (36)
New Jersey (265)
New York (169)
North Carolina (143)
Northern California (254)
Ohio (25)
Pennsylvania (108)
South America (135)
Southern California (269)
Texas (66)
Washington State (47)
90,779 Results for "isto biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Isto Biologics Unveils Fibrant Liberty(TM): An Advanced Allograft Solution Designed for Rapid and Consistent Hydration
Isto Biologics, a global leader in regenerative and autologous therapies, announced the launch of Fibrant Liberty™, a pioneering development within its Fibrant line of allograft solutions.
May 8, 2024
·
2 min read
Deals
Advanced Biologics Elevates Biologic Innovations Through Merger with Isto Biologics.
Advanced Biologics (known commercially as Biologica Technologies), a California-based company known for their innovative biologic solutions, announced today their successful merger with Isto Biologics, a global leader in regenerative and autologous therapies.
October 18, 2023
·
3 min read
Deals
Theracell acquired by Isto Biologics
TheraCell Inc., a leading allograft solution company, announced that it has been acquired by Isto Biologics, a leader in surgical-based, orthobiologic regeneration technologies and cell-based therapies.
April 5, 2022
·
2 min read
News
Webinar: Revolutionizing Biologics Discovery: Harnessing the Power of AI and Patent Data
This webinar explores the pivotal role of patent data in overcoming the data challenges faced by generative AI models in drug discovery, particularly for biologics. Watch now.
October 23, 2024
·
1 min read
·
BioSpace Insights
Approvals
AstraZeneca Wins Rare Autoimmune Indication for Asthma Biologic Fasenra
With the FDA’s approval, Fasenra will compete with GSK’s Nucala, which in December 2017 became the first biologic approved for eosinophilic granulomatosis with polyangiitis.
September 19, 2024
·
2 min read
·
Tristan Manalac
BIOSECURE Act
WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow
WuXi AppTec looks to unload its Philadelphia manufacturing sites and WuXi Biologics slows its rapid expansion in the U.S. as the companies await the Senate’s review of the BIOSECURE Act that threatens to cut them off from U.S. biopharma.
October 8, 2024
·
5 min read
·
Ben Hargreaves
Press Releases
Biologics Market Size to Reach USD 699.5 Billion by 2032, Impelled by Emergence of Advanced Drug Delivery Systems
Biologics Market Outlook 2024-2032:
August 8, 2024
·
14 min read
Press Releases
Chime Biologics and Korean Listed Company MedPacto Form Strategic Partnership to Accelerate Global Biologics Development and Manufacturing
November 1, 2024
·
1 min read
China
WuXi Biologics Takes Net Profit Hit Despite Inking Record Number of New Projects
With the potential passage of the BIOSECURE Act looming, WuXi Biologics reported a 24% drop in net profit in the first half of 2024.
August 22, 2024
·
2 min read
·
Tristan Manalac
Sponsored
Sino Biological’s New Center for Bioprocessing (C4B): US-Based CRO Services
In October 2023,
Sino Biological, Inc.
opened its
Center for Bioprocessing (C4B)
in Houston, Texas. The C4B represents a considerable global expansion of the company’s contract research service capabilities.
September 9, 2024
·
3 min read
1 of 9,078
Next
